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Abstract
Background: The most efficient method for enhancing solubility of recombinant proteins appears
to use the fusion expression partners. Although commercial fusion partners including maltose
binding protein and glutathione-S-transferase have shown good performance in enhancing the
solubility, they cannot be used for the proprietory production of commercially value-added
proteins and likely cannot serve as universal helpers to solve all protein solubility and folding issues.
Thus, novel fusion partners will continue to be developed through systematic investigations
including proteome mining presented in this study.
Results: We analyzed the Escherichia coli proteome response to the exogenous stress of guanidine
hydrochloride using 2-dimensional gel electrophoresis and found that RpoS (RNA polymerase
sigma factor) was significantly stress responsive. While under the stress condition the total number
of soluble proteins decreased by about 7 %, but a 6-fold increase in the level of RpoS was observed,
indicating that RpoS is a stress-induced protein. As an N-terminus fusion expression partner, RpoS
increased significantly the solubility of many aggregation-prone heterologous proteins in E. coli
cytoplasm, indicating that RpoS is a very effective solubility enhancer for the synthesis of many
recombinant proteins. RpoS was also well suited for the production of a biologically active fusion
mutant of Pseudomonas putida cutinase.
Conclusion:  RpoS is highly effective as a strong solubility enhancer for aggregation-prone
heterologous proteins when it is used as a fusion expression partner in an E. coli expression system.
The results of these findings may, therefore, be useful in the production of other biologically active
industrial enzymes, as successfully demonstrated by cutinase.
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Background
Escherichia coli have been widely used as a host to produce
valuable commercial, industrial, and therapeutic proteins.
There are several disadvantages with this system, however,
especially for the expression of eukaryotic proteins. For
example, when randomly selected 2,078 full-length genes
of Caenorhabditis elegans were expressed in E. coli cyto-
plasm, only 11% of genes yielded significant amounts of
soluble material [1]. Several different approaches have
been taken to resolve the solubility problem in the past
and include (1) truncation of long multi-domain proteins
into short and separate domains [2] ; (2) co-expression of
molecular chaperones or foldases [3]; (3) enabled secre-
tion to the periplasm where disulfide bonds can be prop-
erly formed with the help of an oxidative environment
and Dsb protein families [4]; (4) co-expression of ami-
noacyl tRNA cognates to amino acids encoded by rare
codons [5]; and more recently (5) use of a fusion expres-
sion partner [6,7]. The most efficient method for enhanc-
ing solubility and folding efficiencies of recombinant
proteins appears to be the latter (fusion expression part-
ners) which includes maltose binding protein (MBP) [8],
thioredoxin (Trx) [9], human ferritin heavy chains (hFTN-
H) [10], and glutathione-S-transferase (GST) [11].
Although these fusion partners have shown good per-
formance in enhancing the solubility and folding of some
recombinant proteins [12], they likely cannot serve as uni-
versal helpers to solve all protein solubility and folding
issues. Thus, novel fusion partners will continue to be
developed through systematic investigations including
proteome mining.
In the present study, we found that the level of RpoS sig-
nificantly increased during the stress caused by guanidine
hydrochloride through proteome-wide mining involving
the stress response of E. coli BL21(DE3). As an N-terminus
fusion expression partner, RpoS dramatically increased
the solubility of the following heterologous proteins
(human minipro-insulin (mp-INS), human epidermal
growth factor (EGF), human prepro-ghrelin (ppGRN),
human interleukin-2 (hIL-2), human activation induced
cytidine deaminase (AID), human glutamate decarboxy-
lase (GAD448–585), Pseudomonas putida cutinase (CUT),
human ferritin light chain (hFTN-L), human granulocyte
colony-stimulating factor (G-CSF), and cold autoinflam-
matory syndrome1 (NALP3) NACHT domain (NACHT)).
We also have demonstrated an increased yield of a biolog-
ically active fusion mutant of heterologous bacterial cuti-
nase that is expected to be of significant biotechnical and
commercial interest.
Results and discussion
Guanidine hydrochloride-induced proteome response of E. 
coli and finding of the aggregation-resistant protein, RpoS
Exogenous stresses including heat shock and GdnHCl
[13-15] often results in the misfolding and aggregation of
proteins within the cell. Therefore, it would seem reason-
able to presume that intracellular proteins which exist in
their native soluble forms even under stress conditions
have an intrinsic ability to remain efficiently folded com-
pared to proteins that unfold or aggregate under the same
stresses. GdnHCl stress facilitates the release of periplas-
mic proteins through increased membrane permeability
[16-18] and hence could be regarded as an osmolyte. We
investigated changes of the proteome profile of E. coli
when the stress reagent, guanidine hydrochloride, was
added to growing bacterial cultures, by applying 2-dimen-
sional gel electrophoresis (2-DE). Compared to non-stress
condition, the total number of intracellular soluble pro-
teins was reduced to 731 from 788, which indicates that
many proteins aggregated under the stress condition
induced by GdnHCl. What was surprising is that the RpoS
expression level (i.e. protein spot intensity estimated
through analysis of 2-DE gel images, Fig. 1. and Table 1)
increased 6-fold compared to the non-stress situation. In
addition to RpoS, we found several other proteins (Table
1), the expression level of which more than 1.9-fold
increased in response to the stressor GdnHCl, including
HSP60 chaperonin (57 kD), chaperone HtpG (71 kD),
transcription elongation protein NusA (55 kD), DNA
gyrase subunit A (97 kD), formate acetyltransferase 1 (85
kD), succinate dehydrogenase flavoprotein subunit (64
kD), etc. Since the synthesis yield of target protein can be
significantly reduced, the molecular mass of proteins to be
used as fusion expression partner should not be too high.
That is, although the large amount of fusion protein is
synthesized, the actual amount of the target fusion-free
protein could be very low if the fusion partner is too big.
RpoS (38 kD) is a relatively small protein among the
stress-responsive proteins we found and was highly effec-
tive in enhancing the solubility of target proteins.
RpoS, stress responsive RNA polymerase sigma factor is a
well-known universal stress regulator controlling many
proteins under various stress conditions, e.g. the onset of
the stationary phase [19], and carbon starvation [20].
RpoS was previously reported to be induced by osmotic
stress [16] and heat shock [21]. We also observed that the
RpoS expression level increased 3- to 5-fold in response to
heat shock (data not shown). Muffler et al. [21] reported
that the duration of stability of RpoS in response to heat
shock stress is maintained by the direct- or indirect-bind-
ing of DnaK. Bound DnaK appears to assist the effective
folding of RpoS and also protect RpoS against the action
of ClpP, a protease that degrades RpoS [21]. From this
point of view, RpoS may serve as a solubility enhancer inBMC Biotechnology 2008, 8:15 http://www.biomedcentral.com/1472-6750/8/15
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E. coli cytoplasm, when used as a fusion expression part-
ner upon the expression of aggregation-prone heterolo-
gous proteins.
Expression of aggregation-prone heterologous proteins 
using RpoS as fusion partner
We used RpoS as an N-terminus fusion expression partner
for the synthesis of numerous heterologous proteins [mp-
INS, EGF, ppGRN, hIL-2, AID, GAD448–585, CUT, hFTN-L,
G-CSF, and NACHT (Fig. 2 and Table 2 for expression sys-
tem construction)]. Stenström et al. [22] reported that the
codon following an AUG start triplet (+2 codon) signifi-
cantly affects gene expression in E. coli, and the second
codon starting with A is most advantageous to achieve an
enhanced expression level. The second codon of RpoS is
AGT (encoding Ser) that seems to be favorable second
codon based on the report of Stenström et al. [22]. As
shown in Figure 3B and Table 3, all heterologous proteins
expressed directly without RpoS fusion formed insoluble
inclusion bodies resulting in nearly negligible solubility.
Compared to these results, it seems surprising that when
the same heterologous proteins were expressed with the
fusion of RpoS, the solubility of these foreign proteins
dramatically increased (Fig. 3A and Table 3), thereby indi-
cating that E. coli RpoS is a highly effective solubility
enhancer for aggregation-prone heterologous proteins.
Table 3 compares the effect of RpoS- and GST fusion on
the solubility enhancement for heterologous proteins. In
the fusion expression of CUT, GAD448–585, and mpINS,
the effect of RpoS fusion was much higher, whereas GST
fusion was significantly more effective in the expression of
AID, NACHT, and hFTN-L. This result indicates that there
E. coli proteome profiles under non-stress and GdnHCl-stress condition Figure 1
E. coli proteome profiles under non-stress and GdnHCl-stress condition. (A) 2-DE gel image of E. coli proteome 
under the non-stress condition. (Arrow indicates RpoS spot under non-stress condition.) (B) 2-DE gel image of E. coli pro-
teome under GdnHCl-stress condition (Arrow indicates RpoS spot under GdnHCl-stress condition). (Figure in a box presents 
relative spot intensities of RpoS, analyzed under non-stress and GdnHCl-stress conditions.)BMC Biotechnology 2008, 8:15 http://www.biomedcentral.com/1472-6750/8/15
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are no universal helpers to solve all protein solubility
issues. Table 3 also shows that the results of direct- and
fusion expression of heterologous proteins are highly
reproducible.
Moreover, the plasmid vector for the expression of poly-
histidine-tagged fusion mutant of G-CSF
[(His)6::RpoS::(D4K)::G-CSF] was constructed (Fig. 2) to
purify fusion-free G-CSF. After (His)6::RpoS::(D4K)::G-
CSF was bound onto the ProBond resin (Ni+2) column,
the enterokinase proteolysis was carried out in a batch
mode, and subsequently the digested product was col-
lected and centrifuged. SDS-PAGE and Western blot anal-
yses of the supernatant show that the recombinant G-CSF
was easily released from the Rpos-fusion protein and was
Table 1: Result of proteome-wide finding of some aggregation-resistant E. coli proteins
Gene namea Access No.a Protein namea pI/MW(kDa) Sequence coveraged Scored Fold change
Theoreticalb Experimentalc
rpoS P13445 RNA polymerase sigma 
factor rpoS
4.89/37.97 5.08/38.95 19 36 6.21
groL P0A6F5 HSP60 chaperonin 4.85/57.20 4.90/58.63 16 34 2.13
htpG P0A6Z3 Chaperone protein htpG 5.09/71.38 5.14/66.37 9 27 3.10
nusA P0AFF6 Transcription 
elongationprotein nusA
4.53/54.87 4.69/59.09 16 44 3.46
gyrA P0AES4 DNA gyrase subunit A 5.09/96.96 5.20/92.23 21 29 1.95
pflB P09373 Formate acetyltransferase 
1
5.69/85.23 5.68/83.51 19 39 3.26
sdhA P0AC41 Succinate dehydrogenase 
flavoprotein subunit
5.85/64.42 5.70/65.73 25 43 2.16
a Gene name, accession number, and protein name were obtained from ExPASy Proteomics Server [35].
b Theoretical values of pI and Mw were calculated using "Compute pI/Mw tool" [36].
c Experimental values of pI and Mw were estimated through 2-DE gel image analysis in the present study.
d Sequence coverage and score values were calculated using "ALDENTE : PEPTIDE MASS FINGERPRINTING TOOL" [37].
Table 2: Primers used for the cloning of genes encoding various heterologous proteins
Heterologous proteins Primer sequences
Direct expression Fusion expression
mp-INS Sense cat atg ttt gtc aac caa cat ctc gag ttt gtc aac caa cat
Antisense aag ctt tta gtt aca gta gtt c aag ctt tta gtt aca gta gtt c
EGF Sense cat atg aac tct gac tcc gaa tgc ctc gag aac tct gac tcc gaa tgc
Antisense aag ctt tta acg cag ttc cca cca aag ctt tta acg cag ttc cca cca
ppGRN Sense cat atg ggc tcc agc ttc ctg ctc gag ggc tcc agc ttc ctg
Antisense aag ctt tca ctt gtc ggc t aag ctt tca ctt gtc ggc t
hIL-2 Sense cat atg gca cct act tca agt ctc gag gca cct act tca agt
Antisense aag ctt tta tca agt cag tgt aag ctt tta tca agt cag tgt
AID Sense cat atg gac agc ctc ttg atg aac ctc gag gac agc ctc ttg atg aac
Antisense aag ctt tca taa caa aag tcc ca aag ctt tca taa caa aag tcc ca
GAD448–585 Sense cat atg cgc cac gtt gat gt ctc gag cgc cac gtt gat gt
Antisense atc gat tta taa atc ttg tcc atc gat tta taa atc ttg tcc
CUT Sense cat atg gct ccc ctg ccg gat ac ctc gag gct ccc ctg ccg gat ac
Antisense aag ctt tta aag ccc gcg gcg ct aag ctt tta aag ccc gcg gcg ct
aag ctt atg atg gtg gtg atg atg tta aag ccc gcg gcg ct (for metal affinity 
purification)
hFTN-L Sense cat atg agc tcc cag att cgt ctc gag agc tcc cag att cgt
Antisense aag ctt tta gtc gtg ctt gag agt aag ctt tta gtc gtg ctt gag agt
G-CSF Sense cat atg act cca ctc gga cct g ctc gag acc ccc ctg ggc cct gcc
ctc gag gac gat gac gat aaa acc ccc ctg ggc cct gcc (for enterokinase 
digestion)
Antisense aag ctt tca tgg ctg tgc aag aag ctt tca tgg ctg tgc aag
NACHT Sense cat atg act gtg gtg ttc cag ctc gag act gtg gtg ttc cag
Antisense aag ctt tca cag cag gta gta c aag ctt tca cag cag gta gta cBMC Biotechnology 2008, 8:15 http://www.biomedcentral.com/1472-6750/8/15
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present in the form of soluble protein in the supernatant
(Fig. 4).
Bioactivity of the recombinant fusion mutant of cutinase, 
RpoS::CUT
Cutinase has been used as a lipolytic enzyme in the com-
position of laundry and dishwashing detergents to more
efficiently remove immobilized fats [23,24]. In addition,
the oleochemistry industries [25], and pollutant degrada-
tion [26,27] represent other potential uses of cutinase. In
recent years, the esterification and transesterification
properties of cutinase have been intensively exploited and
could be applied usefully in other chemical synthesis
processes [28]. Because of these extensive potential appli-
cations, we were particularly interested in the production
of a bioactive recombinant cutinase. Thus, we cloned the
cutinase gene from the genome of Pseudomonas putida and
expressed it in E. coli using the fusion of RpoS. Cutinase is
known for its hydrolytic activity for a variety of esters
ranging from soluble p-nitrophenyl esters to insoluble
long-chain triglycerides. The hydrolytic activity of cuti-
nase, especially on p-nitrophenyl esters of fatty acids, is
extremely sensitive to fatty acid chain length. Previously,
Lin et al. [29] reported that microbial cutinase lacked a
large hydrophobic surface around the active site, in con-
trast to other lipases and esterases. This structural charac-
teristic of cutinase may be strongly related to high
substrate-specificity, i.e. the extremely low activity on p-
nitrophenyl ester of a long chain fatty acid such as p-nitro-
phenyl palmitate (PNP).
The plasmid vector constructions for direct and fusion expression of heterologous proteins in E. coli Figure 2
The plasmid vector constructions for direct and fusion expression of heterologous proteins in E. coli. (A) Direct 
expression vector, (B) RpoS- and GST-fusion expression vector, (C) Hybrid vector for metal (Ni+2) affinity purification of 
RpoS-CUT-(His)6, (D) Hybrid vector for metal (Ni+2) affinity purification of (His)6-RpoS-D4K-G-CSF, followed by enterokinase 
cleavage.BMC Biotechnology 2008, 8:15 http://www.biomedcentral.com/1472-6750/8/15
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Table 3: Solubility of the expressed recombinant proteins
Heterologous proteins Solubility* of the expressed recombinant proteins (%)
RpoS-fusion expression GST-fusion expression Direct expression
G-CSF 87.4 ± 2.1 91.5 ± 1.5 4.6 ± 0.5
CUT 44.9 ± 2.7 26.2 ± 1.1 3.1 ± 0.2
AID 18.1 ± 3.5 41.7 ± 1.5 8.7 ± 1.6
hFTN-L 47.8 ± 2.1 87.6 ± 2.8 1.7 ± 0.4
NACHT 36.4 ± 4.3 74.8 ± 2.2 8.4 ± 1.3
GAD448–585 59.0 ± 1.8 7.8 ± 2.7 1.9 ± 0.5
hIL-2 60.1 ± 2.4 85.7 ± 1.7 1.3 ± 0.3
EGF 80.4 ± 0.9 92.9 ± 1.2 3.0 ± 0.9
ppGRN 89.2 ± 3.5 90.1 ± 2.3 7.6 ± 0.6
mp-INS 75.9 ± 2.8 13.3 ± 1.0 1.3 ± 0.4
* The solubility was defined as the fraction of the soluble recombinant protein compared to the synthesized total (soluble + insoluble) recombinant 
protein. Average and standard deviation values were calculated based on the results of repeated triplicate experiments.
Results of direct and fusion expression of heterologous proteins Figure 3
Results of direct and fusion expression of heterologous proteins. SDS-PAGE analyses of the RpoS-fusion expressed 
proteins (A), directly (non-fusion) expressed proteins (B), and GST-fusion expressed proteins (C).BMC Biotechnology 2008, 8:15 http://www.biomedcentral.com/1472-6750/8/15
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We assayed the enzymatic activity of our fusion mutant of
cutinase (RpoS::CUT) and demonstrated the same selec-
tive bioactivity as native cutinase to degrade p-nitrophenyl
butyrate (PNB) but not to degrade PNP (Fig. 5A and 5B).
We also purified RpoS::CUT-His6 (Fig. 6A) through Ni2+
affinity chromatography and analyzed the purified
RpoS::CUT-His6 using reversed phase HPLC (Fig. 6B). As
shown in Figure 6B, RpoS::CUT-His6 was analyzed as a
single peak, which seems to indicate that the crafted
mutant molecules of cutinase have uniform and correctly
folded conformation due probably to the help of fusion
partner, E. coli RpoS.
Conclusion
Using 2-dimensional gel electrophoresis, we found that E.
coli  RpoS, RNA polymerase sigma factor was GdnHCl
stress-responsive and highly effective as a strong solubility
enhancer when used as fusion partner for the expression
of aggregation-prone heterologous proteins in E. coli
BL21(DE3). The results of these findings may, therefore,
be useful in the production of other biologically active
industrial enzymes, as successfully demonstrated by cuti-
nase.
Methods
Bacterial strain and plasmids
E. coli strain BL21(DE3) (F-ompT  hsdSB(rB-  mB-)) was
selected under both non-stress and GdnHCl-stress condi-
tions for 2-dimensional gel electrophoresis analysis.
Through PCR amplification using appropriate primers
(Table 2), the genes encoding mp-INS, EGF, ppGRN, hIL-
2 [30], AID, GAD448–585 [31], CUT, hFTN-L [32], G-CSF,
and NACHT were cloned using previously cloned heterol-
ogous genes, except for CUT gene that was cloned from
chromosomal DNA of Pseudomonas putida (ATCC 53552).
The gene clones of mp-INS, ppGRN, AID, G-CSF, and
NACHT were kindly donated by other researchers, as
acknowledged (see Acknowledgements). The EGF gene
was cloned using pCMV6-XL vector (OriGene Technolo-
gies, USA). Each of the recombinant genes above and var-
ious fusion/hybrid genes [rpoS(or GST gene)::(each
heterologous gene)] were inserted into the NdeI-HindIII
site of the same plasmid pT7-7 to construct the expression
vectors. All the heterologous genes above were fused
directly to the RpoS gene (cloned from the chromosomal
DNA of E. coli BL21(DE3)) or GST gene [cloned from the
GST-fusion vector pET42a(+) (Novagen, USA)] without
any linker sequence. Therefore, each expression vector has
no enzymatic cleavage site between rpoS (or GST gene)
and heterologous gene, except for the case of G-CSF. For
the purification of fusion-free recombinant G-CSF, the
D4K sequence for enterokinase digestion was inserted
between RpoS and G-CSF genes to synthesize the polyhis-
tidine-tagged fusion mutant of G-CSF, i.e.
(His)6::RpoS::(D4K)::G-CSF. For the purification of
RpoS::CUT, hexahistidine (His6) was added to the C-ter-
minus of CUT by PCR (Fig. 2). For this, the sequence cod-
ing for N-RpoS::CUT-His6-C was inserted into the NdeI-
HindIII site of plasmid pT7-7.
After complete DNA sequencing of all gel-purified hybrid
plasmids, the E. coli strain BL21(DE3) (F- ompT hsdSB(rB-
mB-)) was transformed with the hybrid plasmids, and
ampicillin-resistant transformants were subsequently
selected using LB-agar plates supplemented with ampicil-
lin (100 mg/l).
Recombinant E. coli culture, gene expression, and 
recombinant protein purification
For shake flask experiments, 250 ml Erlenmeyer flasks
containing 50 ml LB media and ampicillin at 100 mg/l of
culture (37°C and 150 rpm) was used. When the culture
turbidity (OD600) reached 0.5, gene expression was
induced with the addition of IPTG (1 mM), and after a fur-
ther 4 h of cultivation the all recombinant cells (80 mg
wet cell mass) were harvested by centrifugation (13,000
rpm (MICRO17TR, Hanil Science Industrial, Korea) × 5
min) and cell pellets resuspended in 5 ml lysis buffer (10
mM Tris-HCl, pH 7.5, 10 mM EDTA). Cell disruption was
Results of SDS-PAGE and Western blot analysis of RpoS- fusion and fusion-free G-CSF Figure 4
Results of SDS-PAGE and Western blot analysis of 
RpoS-fusion and fusion-free G-CSF. -SDS-PAGE analysis 
(lane M-3): lane M, molecular markers; lane 1, supernatant of 
recombinant E. coli cell lysates containing recombinant (His)6-
RpoS-D4K-G-CSF, which was loaded onto ProBond resin 
(Ni+2) column for metal affinity purification; lane 2, soluble 
fraction of enterokinase(EK)-digested product of (His)6-
RpoS-D4K-G-CSF, containing RpoS and fusion-free G-CSF 
(indicated by an arrow); lane 3, purified soluble fusion-free 
G-SCF. -Western blot analysis (lane 4): result of immunob-
lotting analysis of purified soluble fusion-free G-SCF (loaded 
onto lane 3).BMC Biotechnology 2008, 8:15 http://www.biomedcentral.com/1472-6750/8/15
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achieved using a Branson Sonifier (Branson Ultrasonics
Corp., Danbury, CT). The cell-free supernatant and insol-
uble protein aggregates were separated at 13,000 rpm
(MICRO17TR, Hanil Science Industrial, Korea) for 10
min. The isolated inclusion bodies, if any, were washed
twice with 1 % Triton X-100. Cell-free supernatants and
the washed inclusion bodies were subjected to polyacryla-
mide (14%) gel electrophoresis (PAGE) analysis.
Coomassie-stained protein bands were ultimately
scanned, and the intensity of each recombinant protein
band was estimated using densitometry (Duoscan T1200,
Bio-Rad, Hercules, CA). The solubility of recombinant
proteins was determined by analyzing the fraction of the
soluble recombinant protein compared to the synthesized
total (soluble + insoluble) recombinant protein. Average
and standard deviation values of the solubility were calcu-
lated based on the results of repeated triplicate experi-
ments.
The purification of recombinant G-SCF was accomplished
using metal affinity chromatography. That is, polyhisti-
dine-tagged fusion mutant of G-CSF
[(His)6::RpoS::(D4K)::G-CSF] (Fig. 4) were loaded onto
ProBond resin (Ni+2) column. Prior to sample loading,
the resin was washed twice with 10 column volumes of
binding buffer (50 mM potassium phosphate, 300 mM
KCl, 20 mM imidazole, pH 7.0). Binding buffer contains
20 mM imidazole to minimize non-specific binding of
untagged protein contaminants, and binding was carried
out in a batch mode at 4°C. Afterwards the resin was
Bioactivity of recombinant fusion mutant, RpoS::CUT Figure 5
Bioactivity of recombinant fusion mutant, RpoS::CUT. Assay results using cell-free supernatants from (A) E. coli BL21 
(DE3) host and (B) recombinant E. coli BL21 (DE3) [pT7-RpoS-CUT] producing RpoS::CUT. Both PNB (● ) and PNP (❍ ) were 
used as substrates for the cutinase activity assay. (Concentrations: PNB = 6.6 mM; PNP = 6.6 mM).BMC Biotechnology 2008, 8:15 http://www.biomedcentral.com/1472-6750/8/15
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washed twice with 5–8 ml Tris-HCl (10 mM Tris, pH 8.0)
prior to enterokinase digestion step. The enterokinase
digestion was carried out in a batch mode at 4°C for 10 h
using 5-unit enterokinase (Invitrogen, CA, USA). Then,
the proteolytic product was collected and centrifuged
[3,000 rpm (MICRO17TR, Hanil Science Industrial,
Korea) for 10 min], and the supernatant fraction was sub-
jected to being analyzed by SDS-PAGE and western blot-
ting.
Purification and HPLC analysis of cutinase fusion mutant
For the purification of RpoS::CUT-His6, the soluble frac-
tion was separated after cell disruption by centrifugation
(13,000 rpm (MICRO17TR, Hanil Science Industrial,
Korea)) for 30 min. The cell-free supernatant containing
RpoS::CUT-His6  was loaded onto the ProBond resin
(Ni2+) column (Invitrogen) for affinity purification.
Before the sample loading, the resin was washed twice
with ten column volumes of binding buffer (pH 8.0, 50
mM sodium phosphate, 300 mM NaCl, 10 mM imida-
zole). Binding was carried out in a batch mode at 4°C.
Afterwards, the resin was washed twice with 8 ml washing
buffer (pH 8.0, 50 mM sodium phosphate, 300 mM NaCl,
50 mM imidazole) and eluted with elution buffer (pH
8.0, 50 mM sodium phosphate, 300 mM NaCl, 250 mM
imidazole). The elution buffer in the eluted solution con-
taining the purified RpoS::CUT-His6 was changed with
PBS buffer (137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 2 mM KH2PO4, pH 7.4) using Amicon Ultra-4
centrifugal filter (Millipore, Ireland). Analysis of the puri-
fied RpoS::CUT-His6 was performed with high-perform-
ance liquid chromatography (HPLC) (LC-20A
Prominence, Shimadzu Co. Ltd., Japan). A Shim-pack
CLC-NH2 column (60 × 150 mm, Shimadzu Co. Ltd.,
Japan) was equilibrated with 10 % acetonitrile containing
0.1 % trifluoroacetic acid at a flow rate of 1 ml/min. The
sample was loaded onto the column and eluted with 75 %
acetonitrile. The elution profile was monitored at 215 nm.
Sample preparation for proteome analysis and 2-
dimensioanl gel electrophoresis
Flask culture conditions were identical to those for recom-
binant gene expressions. Cells were grown at 37°C and
then 100 mM GdnHCl was added for the GdnHCl-
induced proteome response when culture turbidity
(OD600) reached 0.5 in the LB media. After further 3 h cul-
Results of purified RpoS::CUT-6xHis analysis Figure 6
Results of purified RpoS::CUT-6xHis analysis. (A) Results of SDS-PAGE analysis of RpoS::CUT-6xHis in soluble fraction 
of E. coli cell lysates (lane 1) and of purified RpoS::CUT-6xHis (lanes 2, 3). (M: molecular marker) (Arrow indicates recombinant 
RpoS::CUT-6xHis). (B) Result of reversed-phase HPLC analysis of the affinity-purified RpoS::CUT-6xHis. (Peaks in red rectan-
gle and dotted circle correspond to the purified RpoS::CUT-6xHis and PBS buffer, respectively.)BMC Biotechnology 2008, 8:15 http://www.biomedcentral.com/1472-6750/8/15
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tivation, the cells were harvested by centrifugation at
6,000 rpm (MEGA17R, Hanil Science Industrial,
Korea)for 15 min (4°C) and then washed twice with 40
mM Tris buffer (pH 8.0). Cell pellets were resuspended in
500 µl of lysis buffer (8 M urea, 4% (w/v) CHAPS, 40 mM
Tris, protease inhibitor cocktail; Roche Diagnostics
GmbH, Mannheim, Germany) and disrupted by sonica-
tion. After sonication (Branson Sonifier 450, USA), the
cell debris and the aggregated proteins were removed by
centrifugation at 12,000 rpm (MICRO17TR, Hanil Sci-
ence Industrial, Korea) for 60 min (4°C), and only solu-
ble proteins were obtained. 2-dimensional gel
electrophoresis was performed as described previously
Kim et al. [33]. Stained gels were scanned using a UMAX
powerlook 1100 scanner and Image Master software v
4.01 (Amersham Biosciences, Uppsala, Sweden) was used
for gel image analysis, including quantification of spot
intensities performed on volume bases (i.e. values calcu-
lated from the integration of spot optical intensity over
spot area).
MALDI-TOF-MS analysis and protein identification
Samples for MALDI-TOF MS analysis were prepared
through the extraction from silver-stained protein spots
according to the previous protocol [33]. Enzymatic diges-
tion was performed with 10 mg/ml of sequencing grade
modified trypsin (Promega, WI, USA) in 25 nM ammo-
nium bicarbonate (pH 8.0) for overnight at 37°C in a sta-
tionary incubator. The trypsin-digested protein spots was
analyzed using a MALDI-TOF-MS system (Voyager DE-
STR, PE Biosystem, Framingham, MA, U.S.A.) by the
Korea Basic Science Institute (Seoul, Republic of Korea),
and peptide mass fingerprinting for protein identification
was performed using MS-Fit [34]. Spectra were calibrated
using a matrix and tryptic autodigestion ion peaks as
internal standards. Peptide mass fingerprints were ana-
lyzed using the MS-Fit [34]. The identification of a protein
with respect to theoretical parameters (pI, molecular
mass, etc.) was accepted if the peptide mass matched
within a mass tolerance of 10 ppm.
Bioactivity assay
A hydrolytic enzyme activity of the recombinant cutinase
fusion mutant was assessed as described below. The
hydrolysis reactions occurred in 96-well microplates at
37°C for 15 min where each well contained 200 µl
enzyme/substrate solution comprised of 106.7 µl phos-
phate buffer (0.1 M, pH 8.0), 13.3 µl Triton X-100 solu-
tion (4 g/l), cutinase solution. The reaction was initiated
by adding 66.7 µl of substrate reagent solution to each
well in the 96-well microplate. Absorbance changes
(∆A415nm per min) were measured using a Bio-Rad micro-
plate reader (Tecan, Austria), and solution A with no
enzyme solution was used as blank. From the absorbance
changes measured at each column, an average absorbance
for a specific reaction condition could then be calculated.
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